Is ZUUZF or JNJ a better dividend investment in 2026?

ZUUZF currently yields 2038.74% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: ZUUZF offers higher current income.

What is the dividend yield difference between ZUUZF and JNJ?

ZUUZF has a forward dividend yield of 2038.74% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 2036.61 percentage points.

Home › Compare › ZUUZF vs JNJ

ZUUZF vs JNJ: Dividend Comparison 2026

ZUUZF yields 2038.74% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZUUZF wins by $11884928662.12M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZUUZF

● Live price

2038.74%

Share price

$0.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$11884928662.15M

Annual income

$10,839,079,198,208,142.00

Full ZUUZF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — ZUUZF vs JNJ

📍 ZUUZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZUUZF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZUUZF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZUUZF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZUUZF

Annual income on $10K today (after 15% tax)

$173,292.56/yr

After 10yr DRIP, annual income (after tax)

$9,213,217,318,476,920.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, ZUUZF beats the other by $9,213,217,318,472,934.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZUUZF + JNJ for your $10,000?

ZUUZF: 50%JNJ: 50%

100% JNJ50/50100% ZUUZF

Portfolio after 10yr

$5942464331.09M

Annual income

$5,419,539,599,106,416.00/yr

Blended yield

91.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ZUUZF

No analyst data

Altman Z

2.5

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZUUZF buys

JNJ buys

No recent congressional trades found for ZUUZF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZUUZFJNJ

Forward yield	2038.74% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$11884928662.15M ✓	$30.3K
Annual income after 10y	$10,839,079,198,208,142.00 ✓	$4,689.40
Total dividends collected	$11810807106.03M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ZUUZF vs JNJ ($10,000, DRIP)

Year	ZUUZF Portfolio	ZUUZF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$214,574	$203,873.60	$10,592	$272.30	+$204.0K → ZUUZF
2	$4,317,995	$4,088,401.09	$11,289	$357.73	+$4.31M → ZUUZF
3	$81,511,262	$76,891,007.50	$12,123	$472.89	+$81.50M → ZUUZF
4	$1,443,740,396	$1,356,523,345.45	$13,141	$629.86	+$1443.73M → ZUUZF
5	$23,999,901,823	$22,455,099,599.78	$14,408	$846.81	+$23999.89M → ZUUZF
6	$374,540,207,060	$348,860,312,108.96	$16,021	$1,151.60	+$374540.19M → ZUUZF
7	$5,488,871,262,756	$5,088,113,241,201.82	$18,122	$1,588.22	+$5488871.24M → ZUUZF
8	$75,561,026,239,303	$69,687,933,988,153.89	$20,930	$2,228.20	+$75561026.22M → ZUUZF
9	$977,429,405,549,079	$896,579,107,473,025.10	$24,792	$3,191.91	+$977429405.52M → ZUUZF
10	$11,884,928,662,145,658	$10,839,079,198,208,142.00	$30,274	$4,689.40	+$11884928662.12M → ZUUZF

ZUUZF vs JNJ: Complete Analysis 2026

ZUUZF — Stock

Zeus North America Mining Corp. engages in the acquisition and exploration mineral properties in Canada. The company owns a 100% interest in the Chlore property located in the Omineca Mining Division of North-Central British Columbia. It also focuses on the Idaho properties. The company was formerly known as Umdoni Exploration Inc. and changed its name to Zeus North America Mining Corp. in February 2024. Zeus North America Mining Corp. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Full ZUUZF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this ZUUZF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZUUZF vs SCHD ZUUZF vs JEPI ZUUZF vs O ZUUZF vs KO ZUUZF vs MAIN ZUUZF vs ABBV ZUUZF vs MRK ZUUZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.